CBL

Dead / Cancelled — Cancelled — Section 8 (as of 20 Dec 2019)

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
85390442
Registration number
4333516
Mark type
Stylized text
Filed
05 Aug 2011
Published for opposition
26 Feb 2013
Registered
14 May 2013
Attorney of record
Craig M. Bell

Goods and services

  • Class 001 — Chemicals: Active chemical ingredients and excipients for use in the manufacture of pharmaceuticals consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for pharmaceutical actives
  • Class 005 — Pharmaceuticals: Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Cellulose esters for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for tablets that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, lipid lowering agents

Owner

Prosecution history

  • 20 Dec 2019 — CANCELLED SEC. 8 (6-YR)
  • 14 May 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 14 May 2013 — REGISTERED-PRINCIPAL REGISTER
  • 26 Feb 2013 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 26 Feb 2013 — PUBLISHED FOR OPPOSITION
  • 06 Feb 2013 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 23 Jan 2013 — LAW OFFICE PUBLICATION REVIEW COMPLETED
  • 23 Jan 2013 — ASSIGNED TO LIE
  • 08 Jan 2013 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 11 Dec 2012 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 11 Dec 2012 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 11 Dec 2012 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 13 Aug 2012 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 13 Aug 2012 — NON-FINAL ACTION E-MAILED
  • 13 Aug 2012 — NON-FINAL ACTION WRITTEN

View this trademark record on Marksy